Cariprazine Completed Phase 3 Trials for Schizophrenic Disorders Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01104792Long-term Study of Cariprazine in Patients With Schizophrenia
NCT01104779Safety and Efficacy of Cariprazine in Schizophrenia
NCT01104766Safety and Efficacy of Cariprazine in Patients With Schizophrenia